---
title: "Lexaria risks Nasdaq delisting after missing $1 minimum bid price rule"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295451695.md"
description: "Lexaria Bioscience received a Nasdaq notice on August 4, 2026, warning of potential delisting due to failure to maintain the $1 minimum bid price. Although a reverse stock split took effect on August 3, 2026, and shares are currently trading above $1, the company faces compliance risks. Lexaria has filed an appeal hearing request with the required fee to stay any suspension while seeking to regain full compliance with Nasdaq listing standards."
datetime: "2026-08-10T21:07:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295451695.md)
  - [en](https://longbridge.com/en/news/295451695.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295451695.md)
generator: "portal-rs"
---

# Lexaria risks Nasdaq delisting after missing $1 minimum bid price rule

-   Lexaria Bioscience received a Nasdaq notice on Aug. 4, 2026, citing failure to regain compliance with the $1 minimum bid rule. \* Nasdaq warned the stock faces delisting, subject to an appeal hearing that would stay any suspension. \* A reverse stock split took effect Aug. 3, 2026; shares are trading above $1 under new CUSIP 52886N604. \* A hearing request was filed with the required fee to keep the listing in place while the company seeks to regain compliance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-26-001302), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [LEXX.US](https://longbridge.com/en/quote/LEXX.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)
- [LEXXW.US](https://longbridge.com/en/quote/LEXXW.US.md)

## Related News & Research

- [Lexaria says DehydraTECH 3.0 retatrutide tablet boosts absorption up to 4,552% in dog study](https://longbridge.com/en/news/296793626.md)
- [Petrolia Noco announces availability of Q2 2026 report](https://longbridge.com/en/news/296871879.md)
- [Ameriprise Financial declares Q3 2026 dividend of R$ 1.48 per unit](https://longbridge.com/en/news/297021432.md)
- [Leggett & Platt declares Q3 2026 dividend of R$ 0.17 per unit](https://longbridge.com/en/news/297016902.md)
- [SoftwareOne attaches full H1 2026 report in correction to earlier release](https://longbridge.com/en/news/297010247.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**